Yeung Wai, Semciw Adam I
1 Department of Physiotherapy, Princess Alexandra Hospital , Brisbane, Australia .
2 School of Health and Rehabilitation Sciences, The University of Queensland , Brisbane, Australia .
Lymphat Res Biol. 2018 Feb;16(1):9-19. doi: 10.1089/lrb.2016.0056. Epub 2017 Mar 27.
Aquatic therapy has several proposed benefits for people with lymphedema. A systematic review of the evidence for aquatic therapy in lymphedema management has not been conducted.
Systematic review and meta-analysis were conducted. Five electronic databases were searched to identify randomized controlled trials (RCTs) of people with lymphedema, which compared aquatic therapy with other lymphedema interventions. Qualitative analysis was undertaken where quantitative analysis was not possible. Study quality was assessed using physiotherapy evidence database (PEDro) scores. The strength of evidence was evaluated using the Grades of Recommendations Assessment, Development and Evaluation (GRADE) approach. Four RCTs of moderate quality (average PEDro score 6.5/10) were included in the review. Two studies provided results for inclusion in meta-analysis. There was moderate-level evidence of no significant short-term differences in lymphedema status (as measured by lymphedema relative volume) between patients who completed aqua lymphatic therapy (ALT) compared to land-based standard care (standardized mean difference [SMD]: 0.14; 95% confidence interval [CI]: -0.37 to 0.64, I = 0%, p = 0.59); and low-quality evidence of no significant difference between ALT and standard care for improving upper limb (UL) physical function (SMD -0.27, 95% CI: -0.78 to 0.23, I = 0%, p = 0.29). No adverse events reported.
Current evidence indicates no significant benefit of ALT over standard land-based care for improving lymphedema status or physical function in people with UL lymphedema. Patient preference should guide the choice of care to facilitate adherence. Further research is required to strengthen the evidence from four studies in people with UL lymphedema, and to establish the efficacy of this intervention in people with lower limb lymphedema. Review registration: PROSPERO (CRD42015019900).
水疗对淋巴水肿患者有多种潜在益处。目前尚未对水疗在淋巴水肿管理中的证据进行系统评价。
进行系统评价和荟萃分析。检索了五个电子数据库,以确定淋巴水肿患者的随机对照试验(RCT),这些试验将水疗与其他淋巴水肿干预措施进行了比较。在无法进行定量分析时进行定性分析。使用物理治疗证据数据库(PEDro)评分评估研究质量。使用推荐分级评估、制定和评价(GRADE)方法评估证据强度。该评价纳入了四项质量中等的RCT(平均PEDro评分为6.5/10)。两项研究提供了可纳入荟萃分析的结果。有中等水平的证据表明,与陆地标准护理相比,完成水淋巴治疗(ALT)的患者在淋巴水肿状态(通过淋巴水肿相对体积测量)方面没有显著短期差异(标准化均数差[SMD]:0.14;95%置信区间[CI]:-0.37至0.64,I=0%,p=0.59);以及低质量的证据表明,ALT与标准护理在改善上肢(UL)身体功能方面没有显著差异(SMD -0.27,95%CI:-0.78至0.23,I=0%,p=0.29)。未报告不良事件。
目前的证据表明,对于改善上肢淋巴水肿患者的淋巴水肿状态或身体功能,ALT并不比标准陆地护理有显著益处。患者偏好应指导护理选择以促进依从性。需要进一步研究以加强来自四项上肢淋巴水肿患者研究的证据,并确定该干预措施对下肢淋巴水肿患者的疗效。综述注册:PROSPERO(CRD42015019900)。